International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Thyroid Heart Disease Was Successfully Treated With Acetazolamide

Author(s) Kadek Adi Sudarmika, Ni Luh Eka Sriayu Wulandari
Country Indonesia
Abstract Introduction: Loop diuretics are currently the first-choice treatment for acutely decompensated HF therapy and for maintaining euvolemia, but the addition of other diuretic agents, such as the carbonic anhydrase inhibitor acetazolamide might be effective for patients with refractory heart failure.
Case: A 35-year-old woman referred from a private hospital came to the emergency unit at Sanjiwani Regional Hospital with complaints of shortness of breath and palpitations, and both legs were swollen. The patient has risk factors for hyperthyroidism and a family history of coronary heart disease. On physical examination, he was conscious of compost mentis with blood pressure 85/50 mmHg, heart rate 79 times/minute, respiratory rate 45 times/minute with saturation 93%, rales (+), oedema in both legs, cold acral; laboratory examination showed TsHs 0.22 uIU/ml, FT4 26.29 pmol/L.
Discussion: Acetazolamide is a carbonic anhydrase inhibitor that reduces proximal tubular sodium reabsorption and may improve diuretic efficiency when added to loop diuretics, thereby potentially facilitating decongestion, was not associated with an increased incidence of adverse events, and associated with a shorter duration of hospital stay.
Conclusion: Acetazolamide is a carbonic anhydrase inhibitor that may improve diuretic efficiency when added to loop diuretics.
Keywords heart failure, hyperthyroidism, acetazolamide
Field Medical / Pharmacy
Published In Volume 6, Issue 1, January-February 2024
Published On 2024-02-11
Cite This Thyroid Heart Disease Was Successfully Treated With Acetazolamide - Kadek Adi Sudarmika, Ni Luh Eka Sriayu Wulandari - IJFMR Volume 6, Issue 1, January-February 2024. DOI 10.36948/ijfmr.2024.v06i01.13245
DOI https://doi.org/10.36948/ijfmr.2024.v06i01.13245
Short DOI https://doi.org/gthqpg
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com